| Ms Eva M Murphy, RPH | |
|
6900 Pecos Rd, Pharmacy #119, North Las Vegas, NV 89086-4400 | |
| (702) 791-9000 | |
| Not Available |
| Full Name | Ms Eva M Murphy |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 6900 Pecos Rd, North Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083665350 | NPI | - | NPPES |
| 10475 | Other | NV | RPH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10475 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Eva M Murphy, RPH 5353 Georgia Peach Ct, Las Vegas, NV 89130-1761 Ph: (702) 384-5055 | Ms Eva M Murphy, RPH 6900 Pecos Rd, Pharmacy #119, North Las Vegas, NV 89086-4400 Ph: (702) 791-9000 |
News Archive
"House Speaker Nancy Pelosi (D-Calif.) and her top lieutenants said Thursday that they are close to corralling the 218 votes they need to move forward with comprehensive legislation that would include a version of the public option prized by liberals as a fundamental pillar of reform," the Washington Post reports (Montgomery and Murray, 10/23).
A new type of sirolimus-eluting stent (SES) successfully showed significantly greater neointimal suppression than the paclitaxel-eluting stent (PES) with greater vessel wall integrity surrounding the stent, confirming the finding of superiority of the SES over the PES stent for the trial's primary endpoint of in-stent late loss.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
Human growth hormone can be used successfully to treat some symptoms of cystic fibrosis, but its impact on the disease itself remains unknown, according to a new report funded by HHS' Agency for Healthcare Research and Quality (AHRQ).
A group of Israeli scientists from the Technion - Israel Institute of Technology, the Weizmann Institute of Science, and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis (MS) patients to the drug Copaxone.
› Verified 8 days ago
Ted Turner, PHARM.D., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 Pecos Rd, North Las Vegas, NV 89086 Phone: 702-271-2895 | |
Hanna A Mekonnen, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4755 W Ann Rd, North Las Vegas, NV 89031 Phone: 702-645-1360 Fax: 702-396-8514 | |
Jenny Casiello, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Wyneisha Edwards, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1408 W Craig Rd, North Las Vegas, NV 89032 Phone: 702-642-2680 | |
Alvin Tseng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Mr. Bryan Lloyd Tarman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 Fax: 702-224-6902 | |
Dr. Andrea Danielle Hawkins, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1445 W Craig Rd, North Las Vegas, NV 89032 Phone: 702-649-3113 Fax: 702-649-3780 |